Warrant Liability (Details Narrative) - $ / shares |
Sep. 30, 2024 |
Sep. 02, 2021 |
Mar. 11, 2021 |
Feb. 03, 2021 |
Dec. 24, 2020 |
Mar. 18, 2020 |
Nov. 06, 2019 |
Sep. 10, 2019 |
---|---|---|---|---|---|---|---|---|
Subsidiary, Sale of Stock [Line Items] | ||||||||
Number of warrants issued | 387,750,000 | |||||||
Private Placement [Member] | ||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||
Number of warrants issued | 22,019 | 34,285 | 7,429 | 7,286 | 44,286 | 114,286 | 35,714 | |
Private Placement [Member] | Minimum [Member] | ||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||
Exercise price | $ 0.49 | |||||||
Private Placement [Member] | Maximum [Member] | ||||||||
Subsidiary, Sale of Stock [Line Items] | ||||||||
Exercise price | $ 5.25 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|